Pink Sheet is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

FTC's First Probiotic Claims Case Emphasizes Need For Well-Designed Studies

This article was originally published in The Tan Sheet

Executive Summary

The Federal Trade Commission delivers on a promise to scrutinize advertising for probiotics with a settlement resolving allegations that Nestle HealthCare Nutrition overstated the benefits of BOOST Kid Essentials

You may also be interested in...



Gerber Good Start Formula Claim, ‘FDA Qualified’ Badge Draw FTC Complaint

Gerber turned “FDA's narrow letter” allowing a qualified health claim for Good Start formula “into a prominent gold badge,” says an FTC attorney. Gerber argues its research “indisputably substantiates” Good Start Gentle Formula products “reduce the risk of the most common infant allergy.”

Gerber Good Start Formula Claim, ‘FDA Qualified’ Badge Draw FTC Complaint

Gerber turned “FDA's narrow letter” allowing a qualified health claim for Good Start formula “into a prominent gold badge,” says an FTC attorney. Gerber argues its research “indisputably substantiates” Good Start Gentle Formula products “reduce the risk of the most common infant allergy.”

Increased Enforcement On Functional Foods Triggers Class Action Risk

Functional foods increasingly are vulnerable to costly class action lawsuits as regulators crack down on advertising claims in this previously oft-ignored category.

Related Content

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

PS104309

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel